These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5122176)

  • 1. B 12 -binding protein.
    Herbert V
    Ann Intern Med; 1971 Nov; 75(5):808-9. PubMed ID: 5122176
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased transcobalamin I in a leukemoid reaction.
    Hall CA; Wanko M
    J Lab Clin Med; 1971 Aug; 78(2):298-301. PubMed ID: 5284678
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum vitamin B12 content and unsaturated vitamin B12-binding capacity in myeloproliferative disease. Value in differential diagnosis and as indicators of disease activity.
    Gilbert HS; Krauss S; Pasternack B; Herbert V; Wasserman LR
    Ann Intern Med; 1969 Oct; 71(4):719-29. PubMed ID: 5360286
    [No Abstract]   [Full Text] [Related]  

  • 4. Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
    Sakr R; Renneville A; Saada V; Cotteret S; Martin JE; Droin N; Selimoglu-Buet D; Besse B; Hollebecque A; Marzac C; Pasquier F; Micol JB; De Botton S; Mir O; Solary E; Willekens C
    Leuk Lymphoma; 2018 Jul; 59(7):1742-1745. PubMed ID: 29115897
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic importance of blood histamine levels in myeloproliferative diseases].
    Gingold N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):541-6. PubMed ID: 6113673
    [No Abstract]   [Full Text] [Related]  

  • 6. Disseminated hepatosplenic mycobacterial infection masking myeloproliferative diseases as leukemoid reaction: a diagnostic pitfall.
    Au WY; Ma SK; Kwong YL
    Leuk Lymphoma; 2001 Aug; 42(4):805-8. PubMed ID: 11697512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonleukemic elevation of serum vitamin B 12 and B 12 -binding capacity levels resembling that in chronic myelogenous leukemia.
    Carmel R; Coltman CA
    J Lab Clin Med; 1971 Aug; 78(2):289-97. PubMed ID: 4105424
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum vitamin B12 and vitamin B12 binding protein in chronic myeloproliferative disorders].
    Iseki T; Kondo H
    Rinsho Ketsueki; 1988 Jul; 29(7):960-8. PubMed ID: 3184482
    [No Abstract]   [Full Text] [Related]  

  • 9. Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours.
    Abukhiran IA; Jasser J; Syrbu S
    J Clin Pathol; 2020 Jun; 73(6):310-313. PubMed ID: 31941653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnosis of eosinophilia in combination with intoxication syndrome].
    Egorov IV; Kotina LN
    Klin Med (Mosk); 2004; 82(8):70-2. PubMed ID: 15468731
    [No Abstract]   [Full Text] [Related]  

  • 11. [B-12 hypervitaminosis due to hypercobalophylinemia].
    Montesinos Fernández C; Velázquez Núñez JM; Ramos Garrido A; Iravedra Gutiérrez JA
    Med Clin (Barc); 2007 Oct; 129(12):479. PubMed ID: 17953917
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the plasma protein biing of [58Co]-vitamin B12. V. Relationship of granulocytes to binding capacity.
    Beal RW; Read WM
    Aust J Exp Biol Med Sci; 1969 Jun; 47(3):387-91. PubMed ID: 5798447
    [No Abstract]   [Full Text] [Related]  

  • 13. The myeloid leukocytoses.
    Ward PC
    Postgrad Med; 1980 Jan; 67(1):219-21, 224-6, 229. PubMed ID: 7350563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Production of B12-binding protein by human leukocytes in vitro].
    Rachmilewitz B; Rachmilewitz M; Gross J
    Harefuah; 1972 Dec; 83(12):538-40. PubMed ID: 4659019
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study on the etiology and clinical significance of reactive plasmacytosis].
    Lu LH; Ye YS; Han ZC
    Zhonghua Nei Ke Za Zhi; 1986 Feb; 25(2):90-3, 126-7. PubMed ID: 3792130
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of vitamin B12 analysis in clinical tests].
    Kondo H
    Nihon Rinsho; 1989 Dec; 48 Suppl():599-603. PubMed ID: 2695674
    [No Abstract]   [Full Text] [Related]  

  • 17. Does an elevated serum vitamin B(12) level mask actual vitamin B(12) deficiency in myeloproliferative disorders?
    Gauchan D; Joshi N; Gill AS; Patel V; Debari VA; Guron G; Maroules M
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):269-73. PubMed ID: 22424943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of vitamin B12 deficiency in patients with myeloproliferative disorders.
    Cinemre H; Serinkan Cinemre BF; Çekdemir D; Aydemir B; Tamer A; Yazar H
    J Investig Med; 2015 Apr; 63(4):636-40. PubMed ID: 25730455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The transcobalamins].
    Zittoun R; Zittoun J
    Nouv Presse Med; 1973 Apr; 2(14):919-24. PubMed ID: 4706643
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radioassay for serum vitamin B-12 and unsaturated B-12-binding capacity: levels in Crohn's disease and myeloproliferative syndromes].
    Léonard JP; Piret L; Beckers C
    Nouv Rev Fr Hematol; 1973; 13(1):95-105. PubMed ID: 4269172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.